RTW Investments, LP 13D and 13G filings for SAB Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | SAB Biotherapeutics, Inc. SABS | RTW Investments, LP | 1,024,335 9.990% | -8,196,337 (-88.89%) | Filing |
| 2024-02-14 07:02 am Purchase | 2023-12-31 | 13G | SAB Biotherapeutics, Inc. SABS | RTW Investments, LP | 9,220,672 9.990% | 9,220,672 (New Position) | Filing |